Colorectal Cancer Trial, Recruiting NCT02328677 Sponsor: University of Utah Condition: Colorectal Cancer
Back to Colorectal Cancer

Colorectal Cancer Trial, Recruiting

NCT02328677
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • Adults between 18 and 89 years old (note: for people enrolled after September 1, 2021, the age range is generally 18 to 69, though older age groups may be included under certain parts of the study — confirm with trial site)
  • Both men and women are eligible
  • People who have been recently diagnosed with colon or rectal cancer at any stage (stage I through IV), or who are currently receiving treatment for colorectal cancer
  • People who speak English (at participating sites in the US) or German (at the University Hospital Heidelberg in Germany)
  • People who are mentally and physically able to give their consent and take part in the study

Who may not be able to join:

  • People who do not meet one or more of the inclusion criteria listed above
  • People who do not have sufficient ability to understand the study or provide informed consent, whether due to language barriers or other reasons

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 19 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Cornelia M Ulrich, MS, PhD, Huntsman Cancer Institute

Phone: (801) 213-5716

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
1 March 2007
Est. completion
1 October 2030

Where this trial is recruiting

🇩🇪 Germany 🇺🇸 United States

Primary endpoints

Disease-free and overall survival; Recurrence

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 19 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov